PD. (AUS) Dr. med. Claudia Paola Ferrier-Guerra

1. Ferrier CP, Bianchetti MG, Beretta-Piccoli CF, Link L, Bachmann C, Weidmann P.
   Studies on the mechanism of acute glucose-induced aldosterone suppression. Role of corticotropin. Acta Endocrinol 1983;103:391-399

IF: 2.101

2. Nuetzi D, Beretta-Piccoli CF, Ferrier CP, Link L, Weidmann P. Studies on acute glucose-induced aldosterone suppression: Role of renin-angiotensin system. Klin Wochenschr 1984;62:213-217

IF: 0.963

3. Bianchetti MG, Weidmann P, Beretta-Piccoli C, Rupp U, Boehringer K, Link L,
   Ferrier C. Disturbed noradrenergic blood pressure control in normotensive members
   of hypertensive families. Br Heart J 1984;51:306-311

IF: 2.060

4. Ferrier CP, Beretta-Piccoli CF, Weidmann P, Mordasini R. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension. Clin Pharmacol Ther 1986;40:525-530

IF: 4.394

5. Beretta-Piccoli CF, Ferrier CP, Weidmann P. Alpha-1-adrenergic blockade and cardiovascular pressor responses in essential hypertension. Hypertension 1986;8:407-417

IF: 4.253

6. Bianchetti L, Ferrier, Beretta-Piccoli C, Fraser R, Morton JJ, Ziegler WH. Adrenergic activity and alosterone regulation: no evidence for alpha-1 adrenoceptor-mediated influence in normal subjects. Clinical Endrocrinol (Oxf) 1986;25:87-95

IF: 3.101

7. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Ferrier C. Blood pressure control in normotensive members of hypertensive families. Kidney Int 1986;29:882-888

IF: 3.101

8. Bianchetti MG, Weidmann P, Beretta Piccoli CF, Ferrier C. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension. Kidney Int 1987;31:956-963

IF: 3.781
 

9. Ferrier C, Weidmann P, Hollmann R, Dietler R, Shaw S. Impaired response of atrial natriuretic factor to high salt intake in hypertension-prone man. N Engl J Med 1988;319:1223.1224

IF: 28.660

10. Ferrier C, Kurtz A, Lehner P, Shaw S, Pusterla C, Saxenhofer H, Weidmann P. Stimulation of renin secretion by potassium-channel activation with cromakalin. Eur J Clin Pharmacol 1989;36:443-447

IF: 1.420

11. Ferrier C, Beretta-Piccoli C,  Weidmann P, Gnaedinger M, Shaw S, Suchecka-Rachon K, Saxenhofer H. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. Am J Nephrol 1989;9:921-299

       IF: 1.091

12. Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw S, Ferrier C. Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 1988;11:483-490

IF: 4.253

13. Saxenhofer H, Angst, Weidmann P, Shaw S, Ferrier C. Corticosteroid-induced stimulation of atrial natriuretic peptide in man. Acta Endocrinol 1988;118:179-186

       IF: 2.101

14. Weidmann P, Schohn D, Gnaedinger MP, Buergisser E, Ferrier C, Jahn H. Hypertensive dysregulation and its modification by calcium channel blockade in
    chronic non-oliguric renal failure. Am I Nephrol 1989; 9:269-278
    IF: 1.091

15. Uehlinger DE, Ferrier C, Weidmann P, Matthieu R, Reuter K, Gnaedinger M, Saxenhofer H, Shaw S, Risen W. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
    J. Hypertens 1989;7:901-907 IF: 3.066

16. Ferrari P, Ferrier C, Franschini L, Saxenhofer H, Shaw S, Weidmann P. Atrial natriuretic factor and autonomic nervous system function in man. Eur J Clin Pharmacol 1990;38:25-30
    IF: 3.066

17. Ferrari P, Weidmann P, Ferrier C, Dietler R, Hollman R, Shaw S. Dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab. 1990; 71:944-951
    IF: 5.641

18. Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen W. Efficacy and tolerance of antihypertensive therapy with the calcium channel blocker verapamil and/or the angiotensin converting enzyme inhibitor enalapril in diabetic patients. Diabetes Care 1991;14:911-914
    IF: 4.180

19. Eisenhofer G, Meredith I, Ferrier C, Cox E, Lambert G, Jennings G, Esler E. Plasma dihydroxyphenylalanine (DOPA) is dependent on sympathetic activity in humans. J Lab Clin Med 1991;117:266-273
    IF: 2.04

20. Eisenhofer G, Esler M, Meredith I, Ferrier C, Lambert G, Jennings G. Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. Clin Sci 1991;80:257-263
    IF: 2.091

21. Angus J, Ferrier C, Sudhir K, Jennings G. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc Res 1993;27:204-210
    IF: 2.996

22. Saxenhofer H, Morger D, Weidmann P, Ferrier C, Shaw S. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol. J Hypertens 1991;9:1049-1056
    IF: 4.253

23. Ferrier C, Esler M, Eisenhofer G, Wallin G, Horne M, Cox H, Lamberg G, Jennings G. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 1992;19:62-69
    IF: 4.253

24. Wallin G, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992;453:45-58

       IF: 4.727

25. Ferrier C, Cox H, Esler M. Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci 1993;84:225-230

       IF: 2.091

26. Ferrier C, Jennings G, Eisenhofer G, Lambert G, Cox H, Kallf V, Kelly M, Esler M. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993;11:1217-1227
    IF: 3.066

27. Ferrier C, North R, Becker G, Townend K, Kincaid-Smith P. Uterine Artery Waveform Indices in the second trimester: Resistance Index, Notch measurement and placental position. J Obstet & Gynaecol 1994;14:237-243

28. North R, Ferrier C, Long D, Townend Kkincaid-Smith P. Uterine artery Doppler Flow Velocity Waveform indices in the second trimester for the prediction of preeclampsia and intrauterine growth retardation. Obstet Gynaecol 1994;83:378-386

IF: 2.252

29. Ferrier C, Kincaid-Smith P et al. Doppler ultrasound of uterine arteries for prediction of superimposed pre-eclampsia in pregnant women with underlying renal disease. Clin Nephrol 1994;42:362-368
    IF: 1.437

30. Ferrier C, Anapalahan M, Becker G, Kincaid-Smith P. Renal vascular changes and uterine artery resistance in pregnant women with renal disease. Nephron 1994;68:405
    IF: 1.561

31. Esler M, Lambert G, Ferrier C, Kaye D, Wallin G, Kallf M, Kelly M, Jennings G. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertens 1995; 17:409-423

IF: 1.025

32. North RA, Ferrier C, Gamble G. Fairley K, Kincaid-Smith P. Prevention of preeclampsia with prophylactic heparin and anti-platelet agents in women with renal disease. Aust NZ Obstet Gynaecol 1995;35:357-362

33.  Depairon M, Ferrier CP, Tutta P, Descombes E, van Melle G, Wauters JP. Is ther a place for duplex screening of brachial artery in haemodialysis patients with vascular  access? VASA  2001; 30: 53-58

34. Ferrier C. Ematuria: Approccio Diagnostico. Tribuna medica Ticinese 2003; 68:5-11

35. Barbey F, Nseir G, Ferrier C, Burnier M, Daudon M. Inhibiteurs de l'anhydrase carbonique et lithiase urinaire phosphocalcique. Nephrologie  2004; 25: 169-172

36. Casella R, Ferrier C, Giudici G, Dickenmann M, Gianini O, Hoesli I, Bachmann A, Sulser T. Surgical management of renal cell Carcinoma during the second trimester of pregnancy. Urol Int 2006; 76-180-181

37. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Askie LM et la on behalf of the PARIS COLLABORATIVE GROUP. Lancet  2007

38. Samaras D, Samaras N, Antonini P, Ferrier C, Vogt-Ferrier N. Determining drug causation from geriatric clinical observations: The case study of a suspected hypersensitivity vasculitis with glomerular involvement associated with lansoprazole. European Geriatric Medicine 2010, 5: 310-313

39. Gamondi C, Galli N, Schönholzer C, Marone C, Zwahlen U, Gabutti L, Bianchi G,  Ferrier C, Cereghetti C & Giannini O.  Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis. Swiss Med Wkly, 2013; 143:

REVIEWS & INVITED BOOK CHAPTERS

1. Ferrier C, Beretta-Piccoli CF, Weidmann P, Bianchetti MG. Different blood pressure responses to diuretic treatment in normotensive subjects with and without a family history of hypertension. J Hypertens 1983;1(Suppl 2):31-34

2. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Link L, Boehringer K, Ferrier C. Calcium and blood pressure regulation in normal and hypertensive subjects. Hypertension 1983;5 (Suppl 2):57-65

3. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Ferrier C, Link L, Gerber A. Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients
   with essential hypertens. J Hypertens 1984;2(Suppl 3):445-448

4. Beretta-Piccoli CF, Ferrier CP, Weidmann P. Cardiovascular effects of short-term selective alpha-1-adrenergic blockade with terazosin in patients with essential hypertension. J. Hypertens 1985;3(Suppl 3):S231-S234

5. Gerber A, Weidmann P, Bianchetti MG, Ferrier C, Laederach K, Mordasini R, Riesen W, Bachmann C. Serum lipoproteins during treatment with the antihypertensive agent indapamide. Hypertension 1985;7(Suppl 2):164-169

6. Weidmann P, Saxenhofer H, Ferrier C, Shaw S. Atrial natriuretic peptide in man. Am J Nephrol 1988;8:1-14

6. Weidmann P, Ferrier CP, Saxenhofer H, Uehlinger DE, Trost BN. Serum lipoproteins during treatment with antihypertensive drugs. Drugs 1988;35(Suppl 6):118-23

8. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperreactivity in human hypertension. Hypertension 1991;17(Suppl III):29-35

9. Weidmann P, Ferrari P, Alleman Y, Ferrier C, Shaw S. Developing essential hypertension: A syndrome involving ANF deficiency? Can J Physiol Pharmacol 1991;69:1582-1591

10. Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen WF. Swiss Hypertension Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients. Drugs 1992;(Suppl 1):74-84

11. Lambert G, Ferrier C, Kaye D, Cox H, Turner A, Jennings G, Esler M. Monoaminergic neuronal activity in subcortical brain regions in essetial hypertension. Blood Pressure  1994:55-66

12. Lambert G, Ferrier C, Jennings G, Kallf M, Kelly M, Turner A, Esler M. Central nervous system norepinephrine turnover un essential hypertension. Ann New York Ac Sci 1995; 763:679-694

13. Ferrier C. Physiopathologie de la preeclampsie: Aspets actuels. Méd Hyg 1995;53:397-400

14. Ferrier C, Wauters JP. Maladies rénales et grossese. Méd Hyg 1995;53:401-405

15. Dürig P, Ferrier C, Schneider H. Hypertensive Schwangerschaftserkrankungen. Therapeutische Umschau, 1999; 56: 561-567

16. Weidmann P, Saxenhofer H, Ferrier C. Atrial natriuretic peptide in man. In: Functional Morphology of the Endocrine Heart. Frossmann WG et al eds, Steinkopf Verlag, Darmstadt 1989

17. Saxenhofer H, Cottier C, Suda S, Shaw S, Ferrier CP, Weidmann P. Limited role of right atrial pressure in the actute control of circulating atrial natriuretic factor. In: American Society of hypertension Symposium Series, Volume 3. Advances in atrial peptide research. Brenner BM, Laragh JH eds, 1989.

18. Lambert GW, Kaye DM, Thompson JM, Turner AG, Ferrier C, Cox HS, Vaz M, Wilkinson D, Meredith IT, Jennings GL, Esler MD. Catecholamine metabolites in internal jugular plasma: A window into the human brain. In: Catecholamines: Bridging Basic Science with Clinical Medicine. Edited by D. Goldstein. Vol. 42 of Advances in Pharmacology, 1997

19. Ferrier C, Gallery E. Pregnancy and therapeutic measures in the patient with diabetic nephropathy.  In: Diabetic Nephropathy. Edited by Geoffrrey Boner & Mark Cooper, 199-206: 2003

20. Roncelli N, Ferrier C, Dürig P, Köferl U, Frey F, Schneider H. Underlying maternal diseases in women who suffered fron severe preeclampsia and HELLP syndrome. N. Roncelli, MD Thesis, University of Berne, 18th December 2000

21. Ferrier Claudia. Uterine Artery Doppler Ultrasound: Prediction of Pregnancy Outcome in Women with Renal Disease. MD THESIS (PD Equivalent) University of Melbourne, 1995.

22. Ferrier Claudia. Il ruolo della certificazione ISO 9001:2008 nel management e nel controllo della qualità di un centro dialisi. MASTER THESIS (MAS), Università della Svizzera Italiana, 2017

ABSTRACTS ACCEPTED AND PRESENTED

Ferrier C, Beretta-Piccoli C, Weidmann P, Mordasini R. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension. First International Symposium on Cardiovascular Pharmacotherapy, Geneva, Switzerland, April 22-26, 1985

Ferrier C, Beretta-Piccoli C, Weidmann P, Gnaedinger M, Shaw S, Suchecka-Tachon K, Saxenhofer H. Hypotension and renal impairment during infusion of atrial nariuretic factor in liver cirrhosis with ascites. Annual Meeting of the Swiss Society of Nephrology, Lausanne, Switzerland, December 2-4, 1988

Ferrier C, Hollman R, Dietler R, Shaw S, Weidmann P. Impaired response of atrial nariuretic factor to high saly intake in hypertension-prone man. 21st Meeting of the American Society of Nephrology, San Antonio, USA, December 11-14, 1988

Ferrier C, Ferrari P, Weidmann P, Keller U, Riesen W. Renal and metabolic effects of antihypertensive therapy with verapamil and/or enalapril in patients with diabetes mellitus. 20th Meeting of the German Society of Nephrology, Berne, Switzerland, September 17-20, 1989

Ferrier C, Jenning G, Angus J, Dart A. Impaired contraction and relaxation in resistance arteries of patients with congestive heart failure. 38th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Hobart, Australia, May 1990

Ferrier C, Esler M, Jennings G, Eisenhofer G, Lambert G, Cox H, Wallin G, Horne M. Catecholamine spillover methodology for studying central nervous system turnover in essential hypertension. 13th Meeting of the International Society of Hypertension, Montreal, Canada, June 26-29, 1990

Ferrier C, Ferrari P, Weidmann P, Keller U, Riesen W. The Swiss Hypertension Treatment Program in Diabetes: Antihypertensive effects of verapamil or enalapril in diabetes associated hypertension. Annual Scientific Meeting of the Australian Diabetes Society, Perth, September 25-27, 1990

Ferrier C, Jennings G, Eisenhofer G, Lambert G, Cox H, Kallf V, Kelly M, Esler M. Evidence for increased subcortical noradrenaline release in essential hypertensive patients. 14th Meeting of the International Society of Hypertension. Madrid, Spain, June 15-19, 1992

Ferrier C, Cox H & Esler M. Elevated total body adrenaline spillover in normotensive members of hypertensive families. 14th Meeting of the International Society of Hypertension, Madrid, Spain, June 15-19, 1992

Ferrier C, North R, Fairley K, Becker G, Dong FP & Kincaid-Smith P. Doppler ultrasound of uterine arteries for prediction of pregnancy-induced hypertension in women with underlying renal disease. 8th World Congress of International Society for the Study of Hypertension in Pregnancy, Buenos Aires, Argentina, November 8-12, 1992

Ferrier C, Anpalahan M, Becker G, Cincotta R & Kincaid-Smith P. Pre-pregnancy renal vascular changes are associated with increased uterine artery resistance and predict the development of preeclampsia. 9th World Congress of International Society for the Study of Hypertension in Pregnancy. Sydney, Australia, March 15-18, 1994

Ferrier C, Taminelli L, Wauters JP. Pregnancy in renal disease. Experience of a single Swiss Center. Annual Meeting of the Swiss Society of Nephrology, Lausanne, Switzerland, December 7-8, 1995

Ferrier C, North R, Becker G, Kincaid-Smith P. Aspirin does not prevent, but delays the onset of preeclampsia in pregnancies with increased uteroplacental resistance. 10th World Congress of International Society for the Study of Hypertension in Pregnancy, Seattle, USA, August, 1996

Ferrier C, Spichtig S, Schneider H, Frey F. Subarachnoidal hemorrhage and ventricular bleeding as first presentation of severe preeclampsia. A case-report. 10th World Congress of International Society for the Study of Hypertension in Pregnancy, Seattle, USA, August, 1996

Ferrier C, Pfister M, Montandon A, Frey F. Obstetric Outcome in women with renal transplant: A 15 years experience. 10th World Congress of International Society for the Study of Hypertension in Pregnancy, Seattle, USA, August, 1996

Ferrier C, Durig P, Frey F, Schneider H. Severe early-onset preeclampsia and HELLP Syndrome are associated with underlying essential hypertension. XIV International Congress of Nephrology, Sydney, Australia, May 25-29 1997

Ferrier C, North R, Becker G, Fairley K, Kincaid-Smith P. Sucessfull pregnancy outcome in women with reflux nephropathy, normal renal function and uterine artery Doppler. XIV International Congress of Nephrology, Sydney, Australia, May 25-29 1997

Ferrier C, Köferl U, Dürig P, Schneider H. LMW-heparin and low-dose aspirin for prevention of preeclampsia: preliminary data of a randomized prospective study. 11th World Congress of International Society for the Study of Hypertension in Pregnancy, Kobe, Japan, October, 1998

Ferrier C, Köferl U, Dürig P, Schneider H. Effects of LMW-heparin and low-dose Aspirin on renal uric acid handling in high risk pregnancies. 12th World Congress of the International Society for Study of Hypertension in Pregnancy. Paris, France, July 2000

Ferrier C, Kürmann P, Antonini P, Belloni F, Vogt N. Acute glomerulonephritis and lanzoprazole therapy: A possible assosiation. 37th Annual Meeting Australian and New Zealand Society of Nephrology. Darwin 5-7 Sept. 2001 (Poster)

Ferrier C, Giudici G, Dickemann M, Gianini O, Hoesli I, Beck EA, Sulser T. Pregnancy, hypertension, suspected thrombophilia and renal mass: An unusual case-report. 39th Annual Meeting Australian and New Zealand Society of Nephrology. Perth 31.8-3 Sept. 2003 (Poster)

Ferrier C, Gallery E, Hösli I, Giudici G, Steiger J. The impact of interdisciplinary follow-up after preeclampsia in subsequent pregnancy. 42nd Annual Meeting Australian and New Zealand Society of Nephrology. Melbourne 14-18 August 2006 (Poster)

Ferrier C, Jozefowsky J, Meister G, Hösli I. Premature contractions: an unsual presentation of primary hyperparathyroidism: A sase Report. International Society of Obstetric Medicine Congress (ISOM). Melbourne 1-3 October 2010 (Poster)

Ferrier C, et al. Outcome of acute kidney injury in a base hospital in Ticino, Southern Switzerland: Experience of a single Center. 46th Annual Meeting of the Swiss Society of Nephrology. Interlaken 3-5 December 2014 (Poster)

Ferrier-Guerra C, et al. Hydrogen –peroxide-based HyperDRYMistR Technology massively reduces bacterial contamination in dialysis center. ISN World Congress of Nephrology. Cape Town, 13-17 March 2015 (Poster)

Scoglio M, et al. Long Term renal outcome in lithium-treated patients: experience of a single swiss centre. 47th Annual Meeting of the Swiss Society of Nephrology. Basel 3-4 December 2015 (Poster)

Ferrier C, et al. Focal and segmental Glomerulosclerosis after long-term heroin use in a Caucasian man: A case report. 15th Asian Pacific Conference of Nephrology (APCN), Perth 17-21 September 2016 (Poster)

Ferrier C, et al. Succesfful pregnancy outcome in a patient with Turner Syndrome and renal malformation. A case-report. 48th Annual Meeting of the Swiss Society of Nephrology. Interlaken 8-9 December 2016 (Poster)

Ferrier C, et al. Sudden severe hypertension: an atypical manifestation of primary hyperparathyroidism. A case report. 53nd Annual Meeting Australian and New Zealand Society of Nephrology. Darwin 4-6 September 2017 (Poster)

Ferrier C, Calciolari S, Bianchetti M. The role of ISO-9001:2008 certification for management and quality control in dialysis: the experience of a Swiss Centre. 49th Annual Meeting of the Swiss Society of Nephrology. Fribourg 7-8 December 2017

Ferrier C, Regusci A, Naccini B, Passera O, Pingitore R, Vogt B. Renal tuberculosis wake-up call: A case report. 50th Annual Meeting of the Swiss Society of Nephrology. Interlaken 6-7 December 2018 (Poster)

Bontadelli F, Ferrier C, Jozefowski J, Vogt B, Pregnancy as a trigger for diagnosis of unknown maternal disease: the importance of early detection. 51 Annual Meeting of the Swiss Society of Nephrology. Interlaken   5-6 December 2019 (Oral presentation)

Ferrier C, Rodoni-Cassis P, Vogt B. The impact of Covid-19 pandemic lockdown on renal patients Care. The Experience of a single Swiss Center. Abstract accepted at the cancelled 52 Annual Meeting of the Swiss Society of Nephrology

Giuliano G, Vogt B, Rodoni-Cassis P, Ferrier C. The many faces of hypercalcemia: Diagnostic challenges in CKD patients. A case-report. Abstract accepted at the cancelled 52 Annual Meeting of the Swiss Society of Nephrology

Bocchi  F, Vogt B, Rodoni-Cassis P, Ferrier C. Recurrent kidney stones behind a rare genetic disease: A case report of a Beckwith-Wiedemann Syndrome. 53 Annual Meeting of the Swiss Society of Nephrology. Interlaken   9-10 December 2021 (Poster)

Ferrier C, Como F, Bocchi F, Vogt B. The Challenging Diagnosis of pseudohyperkalemia: Report of two clinical cases. 54 Annual Meeting of the Swiss Society of Nephrology. Interlaken 8-10 December 2022 (Poster)

Incarichi

• Titolare dello studio medico specialistico in nefrologia, ipertensione e malattia renali in gravidanza
• Terapie emodialitica, dialisi peritoneale, dialisi per vacanzieri, trapianto renale in collaborazione con EOC
• Collaborazione con l'Università di Berna
• Consulente per le malattie renali in gravidanza e la nefrologia alla Clinica Sant’Anna, Sorengo
• Consulente a disposizione della medicina ostetrica presso la Frauenklinik dell’Università di Basilea
• Executive Director del Nefrocentro Ticino e Responsabile per il Quality Management System ISO-9001:2015 

Attività didattica

• Docente studenti bachelor in medicina alla facoltà di medicina (Clinica universitaria di nefrologia e ipertensione) dell’Università di Berna
• Supervisore di tesi di Master e Dottorato per gli studenti e assistenti in medicina dell’Università di Berna (Clinica universitaria di nefrologia e ipertensione)
• Formazione per gli studenti di medicina dell’associazione ASTIM (Associazione Studenti Ticinesi di Medicina) per nefrologia
• Supervisore e responsabile di formazione per medici assistenti in nefrologia (6 mesi riconosciuti SIWF-FMH)

Società Svizzera di Medicina Interna (SGIM)

Società Svizzera di Nefrologia (SGN)

Società Italiana di Nefrologia (SIN)

Australian & New Zealand Society of Nephrology (ANZSN)

Società Internazionale di Nefrologia (ISN)

Società Svizzera di Ipertensione (SSH)

High Blood Pressure Research Council of Australia (HBPRCA)

International Society for Study of Hypertension in Pregnancy (ISSHP)

Australasian Society for Study of Hypertension in Pregnancy (ASSHP)

Society of Obstetric Medicine of Australia and New Zealand (SOMANZ)

Gruppo di eccellenza ticinese di ipertensione arteriosa

Membro del board della Fondazione svizzera del rene